Metro COVID-19 CURE CONTROVERSY: ‘Continue using hydrochloroquine and die’ – Vanguard Nigeria News

Thread starter Kenneth Chimaobi
Start date May 31, 2020

K

Kenneth Chimaobi

Guest

May 31, 2020

#1

COVID-19 CURE CONTROVERSY: ‘Continue using hydrochloroquine and die’

Nigerian health professionals have raised concerns over the use of hydroxychloroquine and chloroquine for the treatment of COVID-19

www.vanguardngr.com

You must log in or register to reply here.

Similar threads

K

Metro 7 persons die as Nigeria records 727 fresh COVID-19 cases –NCDC – The Guardian Nigeria News

Replies: 0

Views: 896

Sep 10, 2021

Kayode Israel

K

Politics Buhari to universities: Find cure for COVID-19 - Guardian Nigeria

Replies: 0

Views: 1K

Dec 19, 2021

Nigeria News

Politics Nigeria can’t continue to be Father Christmas to neighbouring countries – Tinubu - Vanguard Newspaper

Replies: 0

Views: 606

Jun 9, 2023

Nigeria News

K

Metro How COVID-19 vaccination shaped 2021 – Vanguard News

Replies: 0

Views: 1K

Jan 4, 2022

Kayode Israel

K

K

Metro Buhari to receive Sallah homage first time since Covid-19 outbreak – Premium Times Nigeria

Replies: 0

Views: 725

Apr 30, 2022

Kayode Israel

K

Share:

Facebook X Bluesky LinkedIn WhatsApp Email Link

We value your privacy

We use essential cookies to make this site work, and optional cookies to enhance your experience.

See further information and configure your preferences

Accept all cookies Reject optional cookies
Essential cookies

These cookies are required to enable core functionality such as security, network management, and accessibility. You may not reject these.

Optional cookies

We deliver enhanced functionality for your browsing experience by setting these cookies. If you reject them, enhanced functionality will be unavailable.

Third-party cookies

Cookies set by third parties may be required to power functionality in conjunction with various service providers for security, analytics, performance or advertising purposes.

Detailed cookie usage

Privacy policy

Top